IGF1 and breast adenocarcinoma: Auraptene arrests MCF-7 mammary adenocarcinoma cells in the S phase through alteration of some of the transcription genes involved in cell cycle progression, including the down-regulation of cyclin D1 protein expression level and the suppression of insulin-like growth factor-1 (IGF-1).